On this episode of Molecular Moments, Dr. Jim McNally chats with DMPK Senior Director Dr. David Johnson, Ph.D., from BioAgilytix
Working Together to Achieve More for Our Customers and Their Patients
BioAgilytix maintains relationships with leading bioanalytical organizations in the industry in order to build partnerships that will help us to deliver more complete services to our clients.
For bioanalytical CROs, it is of critical importance to build an internal team capable of meeting pharmaceutical and biotech customers’ drug development goals. However, at BioAgilytix we also believe it is equally critical to build strategic partnerships with organizations that can bring additional expertise, solutions, and services to supplement our own, making them more comprehensive and valuable to our customers.
As such, we work scientist-to-scientist with partner organizations and our clients to better enable bioanalytical innovation in the pharmaceutical and biotech industries.
Let’s schedule a conversation!
Clinical Trial and Consulting Services (CTI) is a global CRO delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hepatology, cardiopulmonary, and pediatric populations.
Through this synergistic joint partnership, BioAgilytix is now CTI’s preferred partner for bioanalysis work for all pipeline programs, regardless of stage. Both companies will, when appropriate, cross refer business that could be done more efficiently by the partner.
ATCC is the leading provider of biological materials supporting the scientific community with products, and services. With a history of innovation spanning over 90 years, ATCC offers the world’s largest and most diverse collection of human and animal cell lines, microorganisms, biological products and standards.
ATCC and BioAgilytix’s joint partnership brings together the complementary expertise and resources sponsors need to access, develop, characterize, and store cell lines, and to develop, validate, and perform the robust cell-based assays in which they will be used.